Ventas, Inc. provided earnings guidance for the full year of 2016 and 2017. The company announced that it expects to achieve normalized funds from operations per share for the full year 2016 approximating the high-end of its previously announced guidance range of $4.10 to $4.13. The company expects normalized FFO per diluted share for the full year 2016 to approximate the high-end of its previously announced guidance range of $4.10 to $4.13. The company’s full year 2016 same-store cash NOI growth is expected to be within its prior guidance of 2.5% to 3%. Net debt to adjusted pro forma EBITDA expected to improve to a range of 5.7x to 5.8x at year end 2016 compared to 6.1x at year end 2015. In 2017, the company also expects to continue to grow its overall same-store cash NOI. The company’s preliminary expectations for 2017 include: 2017 normalized FFO per diluted share of $4.12 to $4.18. Total company full year 2017 same-store cash NOI growth of 1.5% to 2.5%, with each segment expected to contribute positively to same-store cash NOI growth. Same-store reported GAAP growth from the portfolio is expected, as is typically the case, to be lower than same-store cash NOI growth due principally to the straight-lining impact of certain of the Company’s leases, and the impact of the extension of substantially all of the Company’s long-term acute care hospital leases with Kindred Healthcare, Inc.